Watch Out for Mix-Ups With GLP-1 Agonists for Diabetes

More patients will come in on injectable diabetes meds Trulicity (dulaglutide), Ozempic (semaglutide), or Victoza (liraglutide).

It's because these three "GLP-1 agonists" lower cardiovascular (CV) risk in some patients with type 2 diabetes.

Other GLP-1 agonists...Adlyxin, Bydureon...are CV neutral.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals